TY - JOUR
T1 - Alcohol intake and stomach cancer risk in Japan
T2 - A pooled analysis of six cohort studies
AU - for the Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan
AU - Tamura, Takashi
AU - Wakai, Kenji
AU - Lin, Yingsong
AU - Tamakoshi, Akiko
AU - Utada, Mai
AU - Ozasa, Kotaro
AU - Sugawara, Yumi
AU - Tsuji, Ichiro
AU - Ono, Ayami
AU - Sawada, Norie
AU - Tsugane, Shoichiro
AU - Ito, Hidemi
AU - Nagata, Chisato
AU - Kitamura, Tetsuhisa
AU - Naito, Mariko
AU - Tanaka, Keitaro
AU - Shimazu, Taichi
AU - Mizoue, Tetsuya
AU - Matsuo, Keitaro
AU - Inoue, Manami
AU - Abe, Sarah K.
AU - Iwasaki, Motoki
AU - Muto, Michihiro
AU - Saito, Eiko
AU - Tanaka, Shiori
AU - Yamaji, Taiki
AU - Charvat, Hadrien
AU - Otani, Tetsuya
AU - Sasazuki, Shizuka
AU - Nishino, Yoshikazu
AU - Tsubono, Yoshitaka
AU - Nomura, Shuhei
AU - Suzuki, Hidekazu
AU - Oze, Isao
AU - Wada, Keiko
AU - Kitamura, Yuri
AU - Nakayama, Tomio
AU - Sadakane, Atsuko
N1 - Funding Information:
National Cancer Center Research and Development Fund, Grant/Award Number: 30-A-15, 27-A-4, 24-A-3; Health and Labour Sciences Research Grants for the Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labour and Welfare, Japan, Grant/Award Number: H21-3jigan-ippan-003, H18-3jigan-ippan-001, H16-3jigan-010. This study was supported by the National Cancer Center Research and Development Fund (30-A-15, 27-A-4, 24-A-3) and the Health and Labour Sciences Research Grants for the Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labour and Welfare, Japan (H21-3jigan-ippan-003, H18-3jigan-ippan-001, H16-3jigan-010). The Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, Japan, is a public interest incorporated foundation funded by the Japanese Ministry of Health, Labour and Welfare and the US Department of Energy. This publication was supported by RERF Research Protocol A2-15. The views of the authors do not necessarily reflect those of the two governments. The members of the research group comprise the following: Manami Inoue (principal investigator), Sarah K. Abe, Motoki Iwasaki, Michihiro Muto, Eiko Saito, Norie Sawada, Taichi Shimazu, Shiori Tanaka, Shoichiro Tsugane, Taiki Yamaji, Hadrien Charvat (until 2017), Tetsuya Otani (until 2006), Shizuka Sasazuki (until 2017) (National Cancer Center, Tokyo); Akiko Tamakoshi (until 2018) (Hokkaido University, Sapporo); Yumi Sugawara, Ichiro Tsuji, Yoshikazu Nishino (until 2006), Yoshitaka Tsubono (until 2003) (Tohoku University, Sendai); Tetsuya Mizoue (National Center for Global Health and Medicine, Tokyo); Shuhei Nomura (The University of Tokyo, Tokyo); Hidekazu Suzuki (Keio University, Tokyo); Hidemi Ito, Keitaro Matsuo, Isao Oze (Aichi Cancer Center, Nagoya); Kenji Wakai (until 2017) (Nagoya University, Nagoya); Yingsong Lin (Aichi Medical University, Aichi); Chisato Nagata, Keiko Wada (Gifu University, Gifu); Tetsuhisa Kitamura, Yuri Kitamura (until 2019) (Osaka University, Osaka); Tomio Nakayama (until 2017) (Osaka International Cancer Institute, Osaka); Mariko Naito (Hiroshima University, Hiroshima); Kotaro Ozasa, Mai Utada, Atsuko Sadakane (until 2019) (Radiation Effects Research Foundation, Hiroshima); Keitaro Tanaka (Saga University, Saga).
Funding Information:
This study was supported by the National Cancer Center Research and Development Fund (30‐A‐15, 27‐A‐4, 24‐A‐3) and the Health and Labour Sciences Research Grants for the Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labour and Welfare, Japan (H21‐3jigan‐ippan‐003, H18‐3jigan‐ippan‐001, H16‐3jigan‐010). The Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, Japan, is a public interest incorporated foundation funded by the Japanese Ministry of Health, Labour and Welfare and the US Department of Energy. This publication was supported by RERF Research Protocol A2‐15. The views of the authors do not necessarily reflect those of the two governments.
Funding Information:
National Cancer Center Research and Development Fund, Grant/Award Number: 30‐A‐15, 27‐A‐4, 24‐A‐3; Health and Labour Sciences Research Grants for the Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labour and Welfare, Japan, Grant/Award Number: H21‐3jigan‐ippan‐003, H18‐3jigan‐ippan‐001, H16‐3jigan‐010.
Publisher Copyright:
© 2021 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
PY - 2022/1
Y1 - 2022/1
N2 - The association between alcohol intake and stomach cancer risk remains controversial. We undertook a pooled analysis of data from six large-scale Japanese cohort studies with 256 478 participants on this topic. Alcohol intake as ethanol was estimated using a validated questionnaire. The participants were followed for incidence of stomach cancer. We calculated study-specific hazard ratios (HRs) and 95% confidence intervals (CIs) for stomach cancer according to alcohol intake using a Cox regression model. Summary HRs were estimated by pooling the study-specific HRs using a random-effects model. During 4 265 551 person-years of follow-up, 8586 stomach cancer cases were identified. In men, the multivariate-adjusted HRs (95% CIs) of stomach cancer were 1.00 (0.87-1.15) for occasional drinkers, and 1.00 (0.91-1.11) for <23 g/d, 1.09 (1.01-1.18) for 23 to <46 g/d, 1.18 (1.09-1.29) for 46 to <69 g/d, 1.21 (1.05-1.39) for 69 to <92 g/d, and 1.29 (1.11-1.51) for ≥92 g/d ethanol in regular drinkers compared with nondrinkers. In women, the multivariate-adjusted HRs were 0.93 (0.80-1.08) for occasional drinkers, and 0.85 (0.74-0.99) for <23 g/d, and 1.22 (0.98-1.53) for ≥23 g/d in regular drinkers compared with nondrinkers. The HRs for proximal and distal cancer in drinkers vs nondrinkers were 1.69 (1.15-2.47) and 1.24 (0.99-1.55) for ≥92 g/d in men, and 1.60 (0.76-3.37) and 1.18 (0.88-1.57) for ≥23 g/d in women, respectively. Alcohol intake increased stomach cancer risk in men, and heavy drinkers showed a greater point estimate of risk for proximal cancer than for distal cancer.
AB - The association between alcohol intake and stomach cancer risk remains controversial. We undertook a pooled analysis of data from six large-scale Japanese cohort studies with 256 478 participants on this topic. Alcohol intake as ethanol was estimated using a validated questionnaire. The participants were followed for incidence of stomach cancer. We calculated study-specific hazard ratios (HRs) and 95% confidence intervals (CIs) for stomach cancer according to alcohol intake using a Cox regression model. Summary HRs were estimated by pooling the study-specific HRs using a random-effects model. During 4 265 551 person-years of follow-up, 8586 stomach cancer cases were identified. In men, the multivariate-adjusted HRs (95% CIs) of stomach cancer were 1.00 (0.87-1.15) for occasional drinkers, and 1.00 (0.91-1.11) for <23 g/d, 1.09 (1.01-1.18) for 23 to <46 g/d, 1.18 (1.09-1.29) for 46 to <69 g/d, 1.21 (1.05-1.39) for 69 to <92 g/d, and 1.29 (1.11-1.51) for ≥92 g/d ethanol in regular drinkers compared with nondrinkers. In women, the multivariate-adjusted HRs were 0.93 (0.80-1.08) for occasional drinkers, and 0.85 (0.74-0.99) for <23 g/d, and 1.22 (0.98-1.53) for ≥23 g/d in regular drinkers compared with nondrinkers. The HRs for proximal and distal cancer in drinkers vs nondrinkers were 1.69 (1.15-2.47) and 1.24 (0.99-1.55) for ≥92 g/d in men, and 1.60 (0.76-3.37) and 1.18 (0.88-1.57) for ≥23 g/d in women, respectively. Alcohol intake increased stomach cancer risk in men, and heavy drinkers showed a greater point estimate of risk for proximal cancer than for distal cancer.
UR - http://www.scopus.com/inward/record.url?scp=85120051779&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85120051779&partnerID=8YFLogxK
U2 - 10.1111/cas.15172
DO - 10.1111/cas.15172
M3 - Article
C2 - 34689390
AN - SCOPUS:85120051779
SN - 1347-9032
VL - 113
SP - 261
EP - 276
JO - Cancer Science
JF - Cancer Science
IS - 1
ER -